Throne Biotechnologies Inc.

CIK: 1912674DEIncorporated: 2011-01-19

Current Offering

$9,996
Target Amount
$1,006,996
Maximum Amount
2022-04-30
Deadline

Security Details

Type: Common Stock
Price per share: $7.59
Shares offered: 1,317+

Offering Costs

Cash commission: 13%
7 - 13 percent
Equity compensation: 2%
Two percent (2%) of securities of the total amount of investments raised in the offering, along the same terms as investors.

Financial Reports

Offering via StartEngine

Offering History

As of 2022-02-25
Raising $9,996 -$1,006,996 via 1,317+ shares of common Stock at $7.59 per share
Deadline: 2022-04-30
Filing date2022-02-25
Current employees5
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$59,519
Cash equi prior fiscal year$208,101
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$409,055
Long term debt prior fiscal year$383,699
Net income most recent fiscal year-$482,168.00
Net income prior fiscal year-$496,520.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$360,000
Short term debt prior fiscal year$360,000
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$2,201,526
Total asset prior fiscal year$2,619,727

Company Information

Corporation
DE
2011-01-19

Latest Metrics

Employees5
Total Assets$2,201,526
Cash on Hand$59,519
Revenues$0.00
Net Income-$482,168.00

Crowdfunding Portals

This company is raising funds through this portal